Brain insulin resistance triggers the accumulation of APP toxic fragments (e.g., Aβ and -C99) either by favoring an aberrant APP cleavage or by inhibiting their clearance [14,15,16,53,59,60]. The gene discussed is APP; the disease is Insulin resistance.